[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351810-105":59,"doc-detail-351810-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","population-specific-microrna-biomarker-discovery-in-breast-ductal-carcinoma-via-explainable-graph-neural-multi-omics-modeling-research-article","Population-specific MicroRNA biomarker discovery in breast ductal carcinoma via explainable graph neural multi-omics modeling - Research article","","South Asian ductal carcinoma patients remain underrepresented in molecular oncology despite the central role of microRNAs in tumor progression, immune regulation, and therapy response. This study profiles microRNA dysregulation in South Asian breast ductal carcinoma and assesses diagnostic, prognostic, and therapeutic value through multi-omics integration, explainable machine learning, and functional validation. Tumor and matched adjacent-normal tissues from 800 patients support subtype prediction and treatment stratification with external validation and anti-miR-21 lipid nanoparticle assays.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/population-specific-microrna-biomarker-discovery-in-breast-ductal-carcinoma-via-explainable-graph-neural-multi-omics-modeling-research-article/351810/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/population-specific-microrna-biomarker-discovery-in-breast-ductal-carcinoma-via-explainable-graph-neural-multi-omics-modeling-research-article/351810.png","ImageObject",300,407,{"name":92,"@type":93},"McGucket","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What disease context and populations does the study focus on?","Question",{"text":113,"@type":114},"The study focuses on breast ductal carcinoma, including DCIS and invasive ductal carcinoma, and specifically targets South Asian populations that are underrepresented in molecular oncology research.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were microRNA biomarkers discovered and validated?",{"text":118,"@type":114},"MicroRNA dysregulation was assessed using miRNA sequencing on tumor and matched adjacent-normal tissues from 800 patients, followed by differential expression, survival modeling, pathway enrichment, and an explainable GAT model. External validation used the TCGA-BRCA dataset, and functional assessment included anti-miR-21 lipid nanoparticle inhibition assays.",{"name":120,"@type":111,"acceptedAnswer":121},"Which microRNAs and model performance results are reported?",{"text":122,"@type":114},"The dysregulated microRNAs include miR-21, miR-155, and miR-200b, with discovery cohort diagnostic performance ranging from AUC 0.78 to 0.92. The GAT model reached AUC 0.96 (95% CI: 0.93–0.98), outperforming Random Forest (AUC 0.94). SHAP analysis highlighted miR-21 and miR-155 as dominant contributors.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351810,1790200553,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Albalawi etal. BMC Cancer (2026) 26:721 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-16060-9](https://doi.org/10.1186/s12885-026-16060-9)  \nRESEARCH Open Access  \nPopulation-specific MicroRNA biomarker discovery in breast ductal carcinoma via explainable graph neural multi-omics modeling  \nEl ham Saleh Albalawi 1*, Jibran Qayyum2 and Junaid Qayyum3,4  \nAbstract  \nBackground Ductal carcinoma, including ductal carcinoma in situ (DCIS) and Invasive ductal carcinoma (IDC), represents a major global health burden, yet South Asian populations remain markedly under-represented in molecular oncology research. MicroRNAs (miRNAs) play critical roles in tumor progression, immune regulation, and therapy response; however, their population-specific relevance remains unclear. This study characterizes miRNA dysregulation in South Asian breast ductal carcinoma and evaluates their diagnostic, prognostic, and therapeutic potential using multi-omics integration, explainable machine learning, and functional validation.  \nMethods Tumor and matched adjacent-normal tissues from clinically confirmed ductal carcinoma patients (n = 800; 500 IDC, 300 DCIS) underwent miRNA-sequencing and clinical annotation. Differential expression, survival modeling, and pathway enrichment analyzes were performed. A Graph Attention Network (GAT) classifier with SHAP-based interpretability was developed for subtype prediction and treatment-response stratification. External validation was performed using theTCGA-BRCA dataset. Anti-miR-21 lipid nanoparticle (LNP) inhibition assays were conducted for functional assessment.  \nResults miR-21, miR-155, and miR-200b showed significant dysregulation in discovery cohort analysis, with diagnostic performance ranging from AUC 0.78–0.92. The GAT model achieved AUC = 0.96 (95% CI: 0 .93–0. 98), outperforming Random Forest (AUC = 0 . 94), and SHAP analysis highlighted miR-21 and miR-155 as the dominant contributors. Proof-of-concept anti-miR-21 LNP assays demonstrated 92% encapsulation efficiency,  \nIC₅₀ = 21.4 nM, and ~ 45% tumor volume reduction in preclinical murine models.  \nConclusions This study presents the first large-scale characterization of miRNA dysregulation in South Asian breast ductal carcinoma and reveals distinct population-specific prognostic behavior, particularly for miR-155 . The combined genomic profiling, explainable GNN-based prediction, and preclinical therapeutic validation support further investigation of miRNA biomarkers for clinical translation. Findings support development of region-tailored liquid biopsy panels and precision therapy strategies for South Asian breast cancer patients.  \n*Correspondence: El ham Saleh Albalawi[es.albalawi@ut.edu.sa](es.albalawi@ut.edu.sa)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nAlbalawi et al. BMC Cancer (2026) 26:721 Page 2 of 35  \nKeywords Population-specific biomarkers, E","cbCaimScIengUIfC","https://ap.wps.com/l/cbCaimScIengUIfC","pdf",4081456,35,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What disease context and populations does the study focus on?\",\"answer\":\"The study focuses on breast ductal carcinoma, including DCIS and invasive ductal carcinoma, and specifically targets South Asian populations that are underrepresented in molecular oncology research.\"},{\"question\":\"How were microRNA biomarkers discovered and validated?\",\"answer\":\"MicroRNA dysregulation was assessed using miRNA sequencing on tumor and matched adjacent-normal tissues from 800 patients, followed by differential expression, survival modeling, pathway enrichment, and an explainable GAT model. External validation used the TCGA-BRCA dataset, and functional assessment included anti-miR-21 lipid nanoparticle inhibition assays.\"},{\"question\":\"Which microRNAs and model performance results are reported?\",\"answer\":\"The dysregulated microRNAs include miR-21, miR-155, and miR-200b, with discovery cohort diagnostic performance ranging from AUC 0.78 to 0.92. The GAT model reached AUC 0.96 (95% CI: 0.93–0.98), outperforming Random Forest (AUC 0.94). SHAP analysis highlighted miR-21 and miR-155 as dominant contributors.\"}]","Population-specific MicroRNA biomarker discovery in breast ductal carcinoma via explainable graph neural multi-omics modeling - Research article | PDF",1790096039,88,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a53d4dd1f2376584ead9029b3ade2095.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c227f682f39e21adf4518594e8edd3bb.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f4e342ab396d658c4748b8e139b06f5.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5b1345d12ff87a5dc75dc0a4ed87383.webp",980,1306]